S06_Solicitation Number 36C79126R0011_Amendment Number 0003_ETMPM-TENS Requirement_Combined Document_Issued 06OCT2026_Fillable.pdf

36C79126R0011-0003

5. PROJECT NUMBER (if applicable)

CODE 7. ADMINISTERED BY

2. AMENDMENT/MODIFICATION NUMBER

CODE

6. ISSUED BY

8. NAME AND ADDRESS OF CONTRACTOR

4. REQUISITION/PURCHASE REQ. NUMBER 3. EFFECTIVE DATE

9A. AMENDMENT OF SOLICITATION NUMBER

9B. DATED

PAGE OF PAGES

10A. MODIFICATION OF CONTRACT/ORDER NUMBER

10B. DATED

BPA NO. 1. CONTRACT ID CODE

FACILITY CODE CODE

Offers must acknowledge receipt of this amendment prior to the hour, and date specified in the solicitation or as amended, by one of the following methods:

The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offers

E. IMPORTANT:

is extended,

(a) By completing Items 8 and 15, and returning __________ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or electronic communication which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY is not extended.

12. ACCOUNTING AND APPROPRIATION DATA

(REV. 11/2016)

is required to sign this document and return ___________ copies to the issuing office. is not, A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.

15C. DATE SIGNED

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(b).

RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by letter or electronic communication, provided each letter or electronic communication makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

D. OTHER

Contractor

16C. DATE SIGNED

14. DESCRIPTION OF AMENDMENT/MODIFICATION

16B. UNITED STATES OF AMERICA

Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

15A. NAME AND TITLE OF SIGNER 16A. NAME AND TITLE OF CONTRACTING OFFICER

15B. CONTRACTOR/OFFEROR

STANDARD FORM 30 PREVIOUS EDITION NOT USABLE

Prescribed by GSA - FAR (48 CFR) 53.243

(Type or print) (Type or print)

(Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

(Number, street, county, State and ZIP Code)

(If other than Item 6)

(Specify type of modification and authority)

(such as changes in paying office, appropriation date, etc.)

(If required)

(SEE ITEM 11)

(SEE ITEM 13)

(X)

CHECK

ONE

13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS,

IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT

(Signature of person authorized to sign) (Signature of Contracting Officer)

1 6

0003 10-06-2026

VA-27-00004517

36C791

Department of Veterans Affairs Enterprise Procurement Office Acquisition Service Four Delta Team 555 Corporate Circle Golden CO 80401-5621 Contracting Officer: Maurice Walker E: maurice.walker@va.gov | P: 720-392-4318

36C791

Department of Veterans Affairs Enterprise Procurement Office Acquisition Service Four Delta Team 555 Corporate Circle Golden CO 80401-5621

To all Offerors:

See Section B.1.2.i of Solicitation

36C79126R0011

X

X X

No accounting or appropriations data are provided at the solicitation stage. The RFP does not obligate funds. The obligation of funds occurs at the Delivery Order level.

proposal package items and all product samples on or before but no later than October 19, 2026, at 3:00PM CDT.

Amendment 0003 to Solicitation Number 36C79126R0011 does not change the common response date for the receipt of all

X 1

Amendment 0003 to Solicitation Number 36C79126R0011 revises and incorporates the following:

1. Removal of Attachment 0004 – BAA Certificate and all related solicitation language.

2. Mandatory separate Attachment 0001 – Price Matrix for each Alternate Electrode (AD) offering.

3. Clarification of VA Rule of Two application within the tiered evaluation structure.

4. Reinforcement that AD SLINs must always be included in the Attachment 0001 - Prime Matrix submission.

5. Statement that alternate AD SLIN Attachment 0001 - Price Matrix submissions supplement, but do not replace the i f h b i i f l (1) i h 0001 i i i h l k requirement of the submission of at least one (1) responsive Attachment 0001 - Price Matrix with every proposal package.

6. Supportive clarifications to Section E.3 and product sample labeling rules.

7. Retention of Attachment 0003 – VAAR 852.219-76 Limitations on Subcontracting Certificate as a material requirement.

Maurice Walker Contracting Officer

SF FORM 30 CONTINUATION PAGE:

1. Amendment 0003 to Solicitation Number 36C79126R0011 includes the following seven revisions:

a. Removal of Attachment 0004 – BAA Certificate and all related solicitation language.

b. New Mandatory Requirement for Separate Attachment 0001 – Price Matrix Files for Each Alternate Electrode Option (AD SLINs).

c. Clarification of How the VA “Rule of Two” Applies Under Tiered Evaluation.

d. Clarification That AD SLINs Must Always Be Included in the Primary TEP Matrix (Not Optional).

e. Clarification That Multiple AD Matrices Supplement—but Do Not Replace— the Required Primary Price Matrix.

f. Minor Clarifying Adjustments to Related Sections (Non-Substantive), including sample labeling and compatibility evaluation.

g. Retention of Attachment 0003 – VAAR 852.219-76 Limitations on Subcontracting Certificate.

2. Amendment 0003 to Solicitation 36C79126R0011 is issued to strengthen clarity, consistency, and evaluation integrity within the ETMPM-TENS national procurement program. Since the solicitation’s release on September 18, 2026, and following more than one-hundred (100 +) prospective Offerors’ questions submitted by the October 5, 2026, Q&A submission deadline, the VA identified several areas requiring formal clarification to preserve fair competition and defensible source selection. The need for this amendment arises from the evolving understanding of how Offerors intend to structure alternate electrode (AD) offer submissions, how end-product country-of-origin (COO) certifications apply under a TAA-only procurement, and how mandatory small-business compliance documents are to be properly enforced.

Earlier amendments corrected pricing tables, SLIN units of issue, and MTRs alignment, but did not address structural submission and evaluation alignment issues revealed during prospective Offerors engagement.

a. Amendment 0003 therefore incorporates seven (7) targeted revisions:

i. Mandatory Separate Attachment 0001 Price Matrix for Each Alternate Electrode AD Offering.

a) Purpose: Enables clean, auditable, one-to-one TEP calculations and avoids pricing ambiguity.

b) Desired Outcome: A fully defensible LPTA/tradeoff evaluation structure consistent with Sections E.2 and E.3.

ii. AD SLINs Are Mandatory Components of the Primary TEP Matrix.

a) Purpose: Prevents omission of AD pricing from the evaluation baseline.

b) Desired Outcome: Protects integrity of the CLIN/SLIN TEP structure.

iii. Enhanced Clarity on AD SLINs Evaluation and Sample Traceability.

a) Purpose: Ensures each AD option is technically evaluated with correct SLIN alignment and device-to-accessory compatibility.

b) Desired Outcome: Eliminates ambiguity in DLS testing under the MTR framework.

iv. Clarification of the VA Rule of Two Within the Tiered Evaluation

Structure.

a) Purpose: Corrects misinterpretation that the rule requires multiple OEM sources; reinforces its only function—determining which tier is opened.

b) Desired Outcome: Ensures consistency with VAAR 815.101-370.

v. Removal of Attachment 0004 – Buy American Act Certificate and All BAA-Related Solicitation Language.

a) Purpose: Aligns solicitation submission requirements with the

Government’s confirmation that the TAA is the exclusive COO regime.

b) Desired Outcome: Eliminates conflicting instructions and avoids Offeror confusion.

vi. Minor Clarifying Adjustments to Section E.3 and Sample Labeling &

Evaluation Rules.

a) Purpose: Improves evaluator clarity and traceable pairing of samples with the correct AD SLINs Attachment 0001 - Price Matrixes.

b) Desired Outcome: To ensure evaluators can consistently and accurately assess each Alternate Electrode (AD) offering, the desired outcome of these clarifications is a fully traceable, error-free evaluation workflow in which every product sample, technical narrative, OEM letter, and FDA clearance is unmistakably linked to the correct AD Price Matrix. These refinements eliminate ambiguity during device-to-accessory compatibility testing, prevent misassociation of samples or documentation, and ensure that each AD configuration is independently and transparently validated against the solicitation’s Minimum Technical Requirements. This results in a streamlined, defensible evaluation process that preserves fairness, consistency, and technical integrity across all Offeror submissions.

vii. Retention of Attachment 0003 – VAAR 852.219-76 Limitations on Subcontracting Certificate.

a) Purpose:

(1) Ensures SDVOSB/VOSB Offerors do not exceed allowable pass-through thresholds.

(2) Ensures SAM.gov representations match proposal claims.

(3) Enables VA to conduct compliance monitoring under

VAAR 852.219-76.

b) Desired Outcome: Maintains statutory Veterans First integrity and prevents improper subcontracting structures.

3. Conclusion: Amendment 0003 does not alter the proposal due-in date or underlying technical requirements. Instead, it introduces necessary clarifications to ensure evaluation is consistent, traceable, end-product COO-accuracy, and defensible source selection methodology, while preserving the VA’s ability to enforce the limitations on subcontracting, end-product eligibility and COO validation, and post-award contract performance compliance. The table below illustrates the revisions incorporated into Amendment 0003 as follows:

Amendment Item Status Correct Description

1. Removal of the Attachment 0004 – BAA Certificate and all related solicitation language. Only the Trade Agreements Act is applicable to the acquisition.

Major Revision

Fully removes Attachment 0004 and deletes all BAA-related submission requirements.

Clarifies that the TAA is the exclusive COO standard for this procurement and that the BAA is waived in full, consistent with FAR Part 25 and Government Q&A.

2. Mandatory separate Attachment 0001 – Price Matrix submission for each Alternate Electrode (AD) SLIN offering.

Major Revision

Requires Offerors proposing more than one AD variant under SLINs X001AD, X002AD, and X005AA to submit a separate, fully completed Attachment 0001 for each offering. Each matrix must include CLIN and all subordinate SLINs (AA–AD). Ensures clean, auditable TEP calculations and prevents price blending.

3. Clarification of the VA’s Rule of Two application within the tiered evaluation structure.

Clarifying Revision

Confirms that the Rule of Two determines which socio-economic tier is opened, not the number of OEM sources. Prevents misinterpretation that two BAA- or TAA-compliant OEMs must exist in a tier.

Ensures consistency with VAAR 815.101-370.

4. Reinforcement that all AD SLINs must always be included in an Attachment 0001 - Price Matrix submission.

Clarifying Revision

Ensures that AD pricing must appear in the primary Attachment 0001 used for formal TEP evaluation. Prevents Offerors from omitting AD from evaluated pricing.

Amendment Item Status Correct Description

5. Statement that multiple offers of alternate electrodes under the AD SLINs are encouraged but require additional Attachment 0001 - Price Matrixes submissions, but do not replace the requirement of all Offerors to submit at least one (1) responsive Attachment 0001

- Price Matrix as a material condition of all responsive proposals.

Clarifying Revision

Confirms that additional AD matrices provide optional alternates but cannot substitute for the required CLIN/SLIN AA–AD pricing structure in the primary evaluation matrix.

Maintains a consistent baseline for LPTA and Best Value evaluation.

6. Supportive clarifications to Section E.3 and product sample labeling rules.

Minor Revision

Enhances technical evaluation clarity by requiring AD samples, technical narratives, OEM letters, and FDA clearances to be traceable to their corresponding AD matrix.

Ensures compatibility checks between each device and each AD variant are performed cleanly and consistently.

7. Retention of the Attachment 0003 – VAAR 852.219-76 Limitations on Subcontracting Certificate as a material condition.

No Change (affirmed as required)

Attachment 0003 remains a mandatory submission. It certifies manufacturer/nonmanufacturer status, enforces statutory limitations on subcontracting, ensures Veterans First program integrity, and enables compliance monitoring under VAAR 852.219-76. Critical for preventing improper pass-throughs and for validating OEM authorization pathways.

(End of Solicitation Number 36C79126R0011 Amendment 0003)

PAGE 1 OF 1. REQUISITION NO.

2. CONTRACT NO. 3. AWARD/EFFECTIVE DATE 4. ORDER NO. 5. SOLICITATION NUMBER 6. SOLICITATION ISSUE DATE

a. NAME b. TELEPHONE NO. (No Collect Calls) 8. OFFER DUE DATE/LOCAL

TIME

9. ISSUED BY CODE 10. THIS ACQUISITION IS UNRESTRICTED OR SET ASIDE: % FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b. RATING

14. METHOD OF SOLICITATION

RFQ IFB RFP

15. DELIVER TO CODE 16. ADMINISTERED BY CODE

17a. OFFEROR CAGE CODE: FACILITY CODE 18a. PAYMENT WILL BE MADE BY CODE

TELEPHONE NO. UEI: EFT:

PHONE: FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER

18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

SEE ADDENDUM

19. 20. 21. 22. 23. 24.

ITEM NO. SCHEDULE OF SUPPLIES/SERVICES QUANTITY UNIT UNIT PRICE AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND APPROPRIATION DATA 26. TOTAL AWARD AMOUNT (For Govt. Use Only)

27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA ARE ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA ARE ARE NOT ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________ 29. AWARD OF CONTRACT: REF. ___________________________________ OFFER COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND DATED ________________________________. YOUR OFFER ON SOLICITATION DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY (BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER)

30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION (REV. NOV 2021)

PREVIOUS EDITION IS NOT USABLE Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:720-497-2304

STANDARD FORM 1449

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

VA-27-00004517

Acquisition Service Four Delta Team

36C79126R0011 09/18/2026

Contract Specialist: John Overstake P:720-497-2304 E: john.overstake@va.gov (720) 497-2304 10-19-2026

3PM CDT

36C791 Department of Veterans Affairs Enterprise Procurement Office Acquisition Services Four Delta Team 555 Corporate Circle Golden CO 80401-5621 Contracting Officer: Maurice Walker E: maurice.walker@va.gov | P: 720-392-4318

Y

334510

1250 Employees

Not Applicable

N/A

36C791

Department of Veterans Affairs Enterprise Procurement Office

555 Corporate Circle Golden CO 80401-5621

36C791

Department of Veterans Affairs Enterprise Procurement Office Acquisition Service Four Delta Team 555 Corporate Circle

See Section B.1.2.i of Solicitation

Department of Veterans Affairs Denver Logistics Center Financial Div.

Attn: Mary (Darcy) Clodio (ORF)|E:dalc.invoices@va.gov 555 Corporate Circle

(303) 273-6231 (303) 215-9140

See CONTINUATION Page

This RFP constitutes a formal invitation for Offerors to submit proposals for the Electro Therapeutic Modalities for Pain Management & Transcutaneous Electrical Nerve Stimulation requirement. The purpose of this RFP is to competitively establish FFP single award IDIQ contracts for the procurement of the commercial devices identified at the CLINs and SLINs listed in Section B. Offerors shall propose to all CLINs/SLINs they wish to be considered for award, submit product samples for all proposed CLINs/SLINs, submit unit pricing on all proposed CLINs/SLINs, submit technical documentation, and evaluation tier appropriate end-product Country-Of-Origin certifications (TAA), and demonstrate full compliance with all universal Minimum Technical Requirements (MTRs) and CLIN/SLIN specific MTRs. Evaluation and award will be conducted on a per CLIN/SLIN basis in accordance with Tiered Set Aside Evaluation procedures and source selection methodologies described in Section E.

Offerors are strongly encouraged to carefully review all solicitation instructions and verify proposal completeness prior to the submission of a proposal.

$0.00 $0.00 See CONTINUATION Page

No accounting or appropriations data are provided at the solicitation stage. The RFP does not obligate funds. The obligation of funds occurs at the Delivery Order level.

Table of Contents

SECTION A

A.1 SF 1449 SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS

AND COMMERCIAL SERVICES

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

1.1 Acknowledgment of Solicitation Amendments:

1.2 Points of Contact (POCs):

1.3 Contracting Officer Authority and COR Designation:

1.4 Contract Modifications:

1.5 Scope of Contract and Change Orders Management:

B.2 STATEMENT OF NEED

B.3 BACKGROUND

3.1 INTRODUCTION & OBJECTIVES:

3.2 SCOPE:

3.3 CONTRACT PERIOD OF PERFORMANCE:

3.4 IDIQ TERMS AND CONDITIONS:

3.5 CONTRACT GUARANTEED MINIMUM AGGREGATE ORDER VALUE:

3.6 MINIMUM TECHNICAL REQUIREMENTS (MTRs):

3.7 CONTRACT ORDERING OFFICERS:

3.8 ORDERING PROCEDURES AND INFORMATION:

3.9 COMMUNICATION OF ORDERS:

3.10 COMMERCIAL PACKAGING:

3.11 COMMERCIAL WARRANTY:

3.12 DELIVERY AND SHIPPING REQUIREMENTS:

3.13 SHIPPING:

3.14 INSPECTION AND ACCEPTANCE:

3.15 PRODUCT REGULATORY COMPLIANCE:

3.16 PRODUCT MODIFICATION, REMOVAL OR RECALL:

3.17 NOTIFICATION OF SUBSTITUTED/ALTERNATIVE SUPPLY AND BACK-

ORDERED:

3.18 ANNUAL PRODUCT TECHNICAL REFRESH MECHANISM:

3.19 ELECTRONIC DATA INTERCHANGE (EDI) and ELECTRONIC INVOICING

REQUIREMENTS:

3.19.1 Introduction to Electronic Data Interchange:

3.19.2 Vendor EDI Exchange Requirements and ANSI X.12 Transaction Standards:

3.19.3 Electronic Invoicing (Tungsten):

3.19.4 Invoice Submission Requirements:

3.19.5 Customer Engagement Portal (CEP):

3.19.6 Quarterly Invoice Reports:

3.19.7 Invoice Issue Resolution:

3.20 VETERAN ENGAGEMENT AND INTERACTIONS:

3.20.1 Scope of Interaction:

3.20.2 Prohibited Activities:

3.20.3 Training and Compliance:

3.21 HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT

(HIPAA):

3.22 CONTRACTOR BUSINESS RELATIONSHIPS:

3.23 LIMITATIONS ON SUBCONTRACTING – MONITORING AND COMPLIANCE:

3.24 SUBCONTRACTING PLANS MONITORING AND COMPLIANCE:

3.25 GRAY MARKET PRODUCTS PREVENTION:

3.26 CONTRACT MODIFICATIONS:

3.27 QUALITY ASSURANCE AND SURVEILLANCE PLAN (QASP):

3.28 CONTRACTOR PERFORMANCE ASSESSMENT REPORTING SYSTEM

(CPARS):

3.28.1 CONTRACTOR PERFORMANCE METRICS:

3.28.1 PERFORMANCE REQUIREMENT SUMMARY TABLE:

SECTION C: CONTRACT CLAUSES

C.1 FAR CLAUSE 52.212-4, CONTRACT TERMS AND CONDITIONS—

COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (DEVIATION OCT 2025)

C.3 FAR CLAUSE 52.216-18, ORDERING (AUG 2020)

C.4 FAR CLAUSE 52.216-19, ORDER LIMITATIONS (OCT 1995)

C.5 FAR CLAUSE 52.216-22, INDEFINITE QUANTITY (DEVIATION NOV 2025

C.6 FAR CLAUSE 52.217-9, OPTION TO EXTEND THE TERM OF THE CONTRACT

(MAR 2000)

C.7 FAR CLAUSE 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB1998)

C.8 VAAR CLAUSE 852.211-70 EQUIPMENT OPERATION AND MAINTENANCE

MANUALS (NOV 2018)

C.9 VAAR 52.211-72 TECHNICAL INDUSTRY STANDARDS (NOV 2018)

SECTION D: ATTACHMENTS AND EXHIBITS

D.1 Attachment 0001_RFP 36C79126R0011_Price Matrix_ETMPM-TENS_Fillable. 52 D.2 Attachment 0003_RFP 36C79126R0011_VAAR Clause 852.219-76_Limitations on Subcontracting_ Certificate of Compliance for Supplies and Product_Fillable.

D.3 Attachment 0005_RFP 36C79126R0011_FAR Provision 52.225-6_Trade Agreements Certificate_Fillable

SECTION E: SOLICITATION PROVISIONS

E.1 FAR PROVISION 52.212-1, INSTRUCTIONS TO OFFERORS - COMMERCIAL

PRODUCTS AND COMMERCIAL SERVICES (SEP 2023)(DEVIATION OCT 2025) ...52

E.2 ADDENDUM TO FAR PROVISION 52.212-1 INSTRUCTIONS TO OFFERORS—

COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES

E.3 RFO PROVISION 52.212-2, EVALUATION - COMMERCIAL PRODUCTS AND

COMMERCIAL SERVICES (DEVIATION OCT 2025)

E.4 ADDENDUM to FAR PROVISION 52.212-2, EVALUATION - COMMERCIAL

PRODUCTS AND COMMERCIAL SERVICES (NOV 2021)

E.5 FAR PROVISION 52.216-1 TYPE OF CONTRACT (APR 1984)

E.6 RFO PROVISION 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY

REFERENCE (FEB 1998)

E.7 RFO PROVISION 52.252-5 AUTHORIZED DEVIATIONS IN PROVISIONS (NOV

2020)

E.8 VAAR PROVISION 852.252-1 SOLICITATION PROVISIONS INCORPORATED BY

REFERENCE (FEB 1998)

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

1.1 Acknowledgment of Solicitation Amendments:

The Offerors to this solicitation hereby acknowledges receipt of the following amendments to this solicitation enumerated and dated as follows (If applicable):

AMENDMENT NUMBER DATE ISSUED

0001 9/30/2026 0002 10/02/2026 0003 10/06/2026

1.2 Points of Contact (POCs):

The Points of Contact (POCs) identified in this section constitute the only authorized representatives of the Government and the Offeror for all matters relating to contract administration. These individuals are the legally recognized parties to the agreement and serve as the exclusive channels through which official communications, contractual actions, and administrative coordination will occur. For the Government, the designated POC is the Contracting Officer (CO), who holds sole authority to bind the United States, issue contractual directions, interpret the terms and conditions of the solicitation and resultant contract, and execute contract modifications in accordance with Revolutionary Federal Acquisition Regulation (RFO/FAR) and Veterans Administration Acquisition Regulation (VAAR) requirements.

Secondary Government points of contact, such as Contract Specialists (CS), may support administrative functions; however, they do not possess authority to alter the contract or commit the Government in any manner. For the Offeror, the designated POC must be a duly authorized company official authorized to legally bind the entity to the Government. This individual must possess the corporate authority to sign and certify proposals, accept and execute contract awards, and enter into contract modifications. The Offeror shall ensure this representative is clearly identified on the Standard Form (SF) 1449 in the “YELLOW” highlighted fields of Section B.1.2(i) and must provide complete contact information including legal business name, business address, primary POC name, telephone number, and email address. This designated POC will be the sole recipient of all official correspondence from the Government and the individual responsible for all contractual engagements throughout the life of the contract. By completing the required fields, the Offeror affirms that the individual identified possesses full legal authority to act on behalf of the company for all binding contractual purposes. No other employee, representative, or affiliate of the Offeror is authorized to negotiate, modify, or engage in contract actions unless formally delegated in writing by the company and acknowledged by the Contracting Officer. This requirement ensures clear lines of communication, prevents unauthorized commitments, preserves the integrity of the contractual relationship, and maintains compliance with all applicable procurement statutes, regulations, and VA acquisition policy.

i. OFFEROR / CONTRACTOR:

Legal Business Name: ______________________________________________

Business Address: _________________________________________________

POC’s Name: _____________________________________________________

Phone Number: ___________________________________________________

E-mail Address: ___________________________________________________

b. GOVERNMENT:

Agency: Department of Veterans Affairs (VA), Enterprise Procurement Office (EPO) - AS4 Delta Team.

Address: 555 Corporate Circle, Golden, CO 80401-5621.

Primary POC Name: Maurice Walker (Contracting Officer) Primary POC Phone Number: (720) 392-4318 Primary POC E-mail Address: maurice.walker@va.gov

Secondary POC Name: John Overstake (Contract Specialist) Secondary POC Phone Number: (720) 497-2304 Secondary POC E-mail Address: john.overstake@va.gov

1.3 Contracting Officer Authority and COR Designation:

The EPO AS4D CO is responsible for providing overall scope of contract oversight, maintaining effective communications between the performing Contractors and the United States Department of Veterans Affairs (VA), ensuring strict contract compliance, administering contracts and contract modifications, and ensuring that annual Contractor Performance Assessment Reporting System (CPARS) performance evaluations are completed at the base Indefinite Delivery Indefinite Quantity (IDIQ) contract level. Any CO assigned to the EPO and acting with his/her warrant authority may take formal action on this contract when a contract action needs to be taken and the primary CO is unavailable. The CO reserves the right to designate a Contracting Officer’s Representative (COR) at the base IDIQ contract level. The CO must issue a COR designation letter to the assigned individual and provide a copy to the Contractor to ensure that all parties understand the limited authority of the COR. The CO must issue Denver Logistic Service (DLS) Ordering Officer (OOs) Authorization Letters to the assigned designees who are granted authority to process delivery orders under this contract.

Only EPO CO’s and designated OOs may order products under this contract.

1.4 Contract Modifications:

The resultant contracts awarded against this solicitation will be Firm-Fixed Price (FFP) IDIQ type contracts, and the terms and conditions of these contracts may only be changed by a written contract modification executed by an EPO AS4D warranted CO.

The resultant performing Contractors must not provide products or services not expressly stated within the awarded FFP/IDIQ contracts. The EPO AS4D CO is the only Government official authorized to modify the resultant contracts to be awarded against this solicitation.

1.5 Scope of Contract and Change Orders Management:

Offerors are hereby advised of the potential for post-award change orders to the resultant contracts to be awarded against this solicitation, which must be incorporated by the execution of bilateral contract modifications when the CO determines in writing that the change order is within the scope of the original IDIQ base contract.

B.2 STATEMENT OF NEED

The Department of Veterans Affairs (VA), Veterans Health Administration (VHA), requires a national, enterprise-wide follow-on procurement and ordering vehicle to ensure the uninterrupted availability of Food and Drug Administration (FDA)-cleared Electro-Therapeutic Modalities for Pain Management (ETMPM) and Transcutaneous Electrical Nerve Stimulation (TENS) devices and accessories.

a. This requirement replaces the expiring legacy IDIQ contract 36C79122D0005 (e.g., expiration date of January 19, 2027) and supports critical non-opioid based pain-management programs across 168 VA Medical Centers, 1,053 Community Based outpatient Clinics (CBOCs), and additional VHA healthcare facilities.

b. This current acquisition effort consolidates and expands the existing legacy TENS procurement program to include Interferential Current Therapy (IFC) devices, short-wave diathermy (SWD) devices (both thermal and non-thermal devices), portable neuromodulation systems for the treatment of headache disorders, electrodes, lead wires, chargers, garment-based applicators, and associated consumables and accessories. Each product included in this requirement is mapped to unique parent Contract Line Item Numbers (CLINs) and discrete subordinate Sub-Line Item Numbers (SLINs) with individualized Minimum Technical Requirements (MTRs) enumerated at the CLIN/SLIN level.

c. VHA’s National Prosthetic and Sensory Aids Service (PSAS) requires continuous access to standardized, durable, FDA-cleared electrotherapeutic devices supporting non-opioid pain-management treatment plans. Demand for ETMPM-TENS devices is nationwide and growing year-over-year, the need is recurring, subject to high-volume ordering, and clinically essential to the VA. The requirement directly supports the VA’s mission to deliver safe, effective, non-pharmacological pain-management solutions to millions of Veterans. The VHA’s PSAS has a bonafide need for the establishment of a VA enterprise-wide ETMPM-TENS product procurement and IDIQ ordering vehicle to ensure:

i. Standardized ETMPM-TENS product quality and clinical consistency;

ii. Streamlined product ordering via the VA’s Remote Order Entry System

(ROES);

iii. Efficient supply-chain management through the VA’s Denver Logistics Services (DLS);

iv. Predictable ETMPM-TENS product unit pricing throughout the ordering period;

v. Sustained and stable long-term successful contract performance delivered by responsible Vendors; and

vi. Protection against ETMPM-TENS product shortages, DLS stock outages, and product supply interruptions.

B.3 BACKGROUND

The Department of Veterans Affairs (VA), Veterans Health Administration (VHA), Prosthetic and Sensory Aids Service (PSAS), has determined a continuing enterprise-wide need for FDA-cleared Electro-Therapeutic Modalities for Pain Management (ETMPM) and Transcutaneous Electrical Nerve Stimulation (TENS) devices and associated accessories.

These products directly support VHA’s national non-opioid pain-management programs and are essential for delivery of safe, standardized, and clinically effective therapeutic care across 168 VA Medical Centers and over 1,000 Community Based Outpatient Clinics (CBOCs).

a. This procurement effort follows the expiring national TENS IDIQ contract number 36C79122D0005, which is scheduled to end on January 19, 2027, and expands the scope of the legacy TENS requirement by incorporating additional ETMPM device categories such as Interferential Current (IFC) units, Short-Wave Diathermy (thermal and non-thermal) systems, neuromodulation devices, and clinically essential consumable supplies (electrodes, leads, gels, and related accessories).

b. VHA market research performed from January through July 2026 confirmed that the commercial marketplace for ETMPM-TENS products is mature, stable, and fully capable of supporting the VA’s nationwide demand. All required device categories are commercially available items manufactured predominantly by a small number of large Original Equipment Manufacturers (OEMs) and distributed through nationwide networks of authorized Durable Medical Equipment (DME) suppliers or distributors. The commercial market shows broad availability, predictable pricing, and no indicators of supply-chain instability, raw-material shortages, or elevated performance risks during the anticipated period of performance.

c. The VA Denver Logistics Service (DLS), operating as the Denver Logistics Center

(DLC), serves as the Government’s centralized receiving, stocking, and distribution facility for ETMPM-TENS products. Under the legacy TENS contract, historical performance demonstrated that authorized distributors reliably delivered ordered products within established 30-day delivery requirements, maintained uninterrupted supply support, and ensured clinical continuity for Veteran patients.

d. The ETMPM-TENS recompete requirement is therefore structured to ensure continued enterprise-wide availability of clinically essential products, alignment with ROES-based ordering workflows, and preservation of standardized product quality at fixed unit prices over the five-year ordering period. This procurement is designated as a national follow-on requirement, not a bundled or consolidated acquisition.

e. Market research identified no mandatory Government sources, Federal excess property, or AbilityOne products capable of meeting the CLIN/SLIN-level Minimum Technical Requirements (MTRs). No Organizational Conflicts of Interest were identified.

f. The acquisition will use multiple single-award Base IDIQ contracts and resultant

FFP/IDIQ Delivery Order contract vehicles awarded at the CLIN/SLIN level to ensure pricing competitiveness, broaden supplier participation, and sustain VA enterprise-wide supply-chain reliability.

g. The results of market research also confirmed the relevance of the principal NAICS 334510 (Electromedical and Electrotherapeutic Apparatus Manufacturing), PSC 6515 (Medical and Surgical Instruments, Equipment, and Supplies), and the continuing applicability of FDA 510(k) clearance, Buy American Act (BAA) is not applicable to this acquisition, Trade Agreements Act (TAA) applicability to this acquisition, and VA-specific prohibitions relating to refurbished products, gray-market products, or other non-authorized products are strictly prohibited in this procurement. These conditions, combined with demonstrated increases year-over-year enterprise-wide demand for ETMPM-TENS products and the absence of VA inventory capable of meeting specifications, establish a clear and well-supported Government requirement for this recompete procurement effort.

h. Accordingly, the VA is issuing this solicitation to establish national ETMPM-TENS contract vehicles that ensure uninterrupted patient care, predictable unit pricing, streamlined enterprise ordering, and sustained delivery of FDA-cleared ETMPM-TENS devices and accessories essential to VHA’s mission of delivering safe, effective, non-pharmacological pain-management treatments to Veterans nationwide.

3.1 INTRODUCTION & OBJECTIVES:

The Department of Veterans Affairs (VA) Enterprise Procurement Office (EPO) and the Denver Logistics Service (DLS), known and operating as Denver Logistics Center (DLC) manage holistic supply chain management for the VA National Audiology, Prosthetics, and Telehealth Programs and supports VA and other Government agencies with professional acquisition and logistical services. The Department of Veterans Health Administration (VHA) Prosthetic and Sensory Aids Service (PSAS) has identified the need to procure Electro-Therapeutic Modalities for Pain Management devices and supplies through EPO and the DLC in order to meet Veteran Patient care needs and align to the MISSION Act to meet the needs of the Veteran. VHA has made a considerable investment organizationally as well as in medical technologies to support advancing health technology and capabilities. The Department of Veterans Health Administration (VHA) National Prosthetic and Sensory Aids Program Office (PSAS) has identified Electro-Therapeutic Modalities for Pain Management devices and supplies as preferred products for consolidated contracting through the Department of Veterans Affairs (VA), Enterprise Procurement Office (EPO), and the Denver Logistics Center (DLC). The objectives are to:

a. Improve the quality of health for the Veteran;

b. Increase the quality of health care available throughout VHA;

c. Improve the efficiency of health care providers and staff;

d. Increase Veterans’ overall satisfaction with VA/VHA;

e. Obtain quality products at lower than current open-market prices and prices advantageous to the scale of VA procurements for the Veteran patient population;

f. Ensure availability and consistency of product for nationwide usage while integrating the DLC ROES program for ordering. Products will be ordered using the DLC’s Remote Order Entry System (ROES) and will be shipped from the DLC directly to the clinic or in some cases the Veteran. This mechanism will be the primary source for contracted products for the VA;

g. Improve operating efficiency throughout the VA; and

h. This contract will also allow for higher level of effective communication between the

Government and Contractor, which is essential for partnering for this performance-based contract to succeed. The success of this Contract is shared between the Government and the Contractor.

3.2 SCOPE:

VA’s purpose under this solicitation and resulting contract is to obtain Electro-Therapeutic Modalities for Pain Management devices and supplies while securing a continuous supply of products. These products are purchased by the VA EPO and DLC for stocking, distribution, and assignment to individual VA medical facilities and subsequent issue to Veteran patients. This provides the Contractor with a single point of contact for all ordering activity under the contract.

All orders will be placed by the CO and duly appointed Ordering Officers to replenish depleted stock. The VA has been providing Electro-Therapeutic Modalities for Pain Management devices and supplies to eligible Veterans for multiple years. The need for Electro-Therapeutic Modalities for Pain Management devices and supplies for Veterans has increased steadily over the years. To meet the increasing demand with the highest level of technology at the lowest prices, VHA National Prosthetic and Sensory Aids (PSAS) has worked in conjunction with DLC and EPO to develop contracts for Electro-Therapeutic Modalities Pain Management devices and supplies that provide the best value. The Department of Veterans Affairs intends to solicit and award a multiple award Indefinite Delivery Indefinite Quantity contract(s) to provide the widest range of technologies for clinicians and Veterans and to ensure that the demand created by the large volume of pain management device prescriptions generated by the VA can be met. The preferred product features shall be defined by clinical prescription which profile the intended user and environment as well as physical/performance specifications. The contract will fulfill the supply requirement for the Electro-Therapeutic Modalities for Pain Management devices and supplies nationwide throughout the VA. The Contractor(s) shall provide an uninterrupted source of supply of various Electro-Therapeutic Modalities for Pain Management devices and supplies that meet or exceed the specifications and deliver within the terms of the contract(s).

Delivery shall take place within 30 calendar days of the ROES delivery order issuance. The delivery orders placed through ROES shall indicate the specific items ordered, item quantities, and all necessary delivery and payment procedures. Implementation of the contracts will be accomplished by the DLC and EPO under the purview of VHA National Prosthetics and Sensory Aids Program Office (PSAS).

3.3 CONTRACT PERIOD OF PERFORMANCE:

Base Year January 20, 2027, through January 19, 2028 Option Year One January 20, 2028, through January 19, 2029 Option Year Two January 20, 2029, through January 19, 2030 Option Year Three January 20, 2030, through January 19, 2031 Option Year Four January 20, 2031, through January 19, 2032

3.4 IDIQ TERMS AND CONDITIONS:

Supply chain management issues are handled by the Denver Logistics Center (DLC). The DLC is paramount in the ordering, receiving, and supply distribution process. The DLC will issue ROES delivery orders to the Contractor which shall indicate the specific item(s) ordered, the quantities of the item(s) ordered, and all necessary delivery and invoicing procedures.

3.5 CONTRACT GUARANTEED MINIMUM AGGREGATE ORDER VALUE:

In accordance with RFO 16.504(a)(d), RFO 16.505(a), and VA acquisition policy, the VA intends to make multiple single-awards of between one (1) and five (5) separate Base IDIQ contracts, each immediately followed by issuance of the corresponding funded FFP/IDIQ Delivery Order at time of award. Awards are made per CLIN/SLIN, and any responsible Offeror may be awarded more than one (1) CLIN/SLINs, resulting in one (1) to five (5) total Base IDIQ contract and resultant FFP/IDIQ Delivery Order awards depending on the outcomes of the competition. Because each CLIN/SLINs is awarded as a single-award IDIQ, there is no further competition at the Delivery Order level under FAR 16.505(b)(2)(i).

a. Consistent with RFO 16.504-1(a), each awarded Base IDIQ contract and resultant FFP/IDIQ Delivery Order shall include its own distinct minimum guaranteed order amount of $5,000.00, which is obligated one time within the Base Year period of performance if required. However, consistent with RFO 16.504-1(a)-(d), the requirement to establish a reasonable maximum quantity/value based on documented program needs, the VA will not assign five

(5) independent ceilings of $500M each. Instead, the VA is establishing a single unified maximum aggregate order value (“contract maximum”) of $500,000,000.00 for the entire ETMPM-TENS procurement program, inclusive of all awards made under this solicitation.

b. This $500,000,000.00 aggregate ceiling represents the total maximum ordering authority for all resultant Base IDIQ contracts and resultant FFP/IDIQ Delivery Orders combined across all five (5) years, if all options are exercised. This aggregate ceiling amount is supported by program demand analysis, historical usage, market research, and VAAM acquisition planning policy. Per RFO 16.504- 1(d), the VA will proportion and assign appropriate maximum ordering values to each awarded Base IDIQ contract and resultant FFP/IDIQ Delivery Order at the time of award, ensuring that the sum of all individual contract maximums does not exceed the aggregate program ceiling of $500,000,000.00. Accordingly:

i. Each Base IDIQ contract has its own separate $5,000.00 minimum guarantee, obligated once at contract award, in accordance with RFO 16.504-1(a).

ii. The maximum aggregate order value for the entire procurement is $500,000,000.00, representing the total combined ceiling for all awarded Base IDIQ contracts across all CLINs/SLINs.

iii. Individual contract maximums will be proportioned from within the $500,000,000.00 aggregate ceiling at the time of award, consistent with RFO 16.504-1(a) and VAAM acquisition planning requirements; the ceilings do not multiply by the number of awardees.

iv. The aggregate ceiling applies program-wide, and total cumulative obligations across all Delivery Orders under all awarded Base IDIQ contracts may not exceed $500,000,000.00 during the five-year ordering period, if all options are exercised.

v. This structure aligns with RFO Subpart 16.5, VAAR, and VAAM requirements for establishing defensible IDIQ minima and maxima and ensures proper ceiling control, fiscal accountability, and compliance with ordering limitations under RFO 16.506.

3.6 MINIMUM TECHNICAL REQUIREMENTS (MTRs):

The Recompete of the ETMPM-TENS Procurement Program establishes a unified, enterprise-wide framework to ensure the VA acquires safe, FDA-cleared, clinically effective electro-therapeutic devices and accessories for nationwide Veteran pain-management care.

Central to this framework are the Universal Minimum Technical Requirements (MTRs) and the structured use of Contract Line Item Numbers (CLINs) and Sub-Line Item Numbers (SLINs).

The Universal MTRs apply to every therapeutic device (CLIN) offered under the program. These requirements mandate that all devices be Original Equipment Manufacturer (OEM) -new, Food and Drug Administration (FDA) 510(k) cleared for home use, fully operational out-of-the-box with included accessories, independent of subscription models or smart-device applications, properly labeled and serialized for logistics tracking, supported by English-language instructions and browser-based patient-training resources, and covered by a one-year warranty with full-replacement protections. These standards ensure clinical reliability, patient safety, regulatory compliance, and supply-chain consistency across all VA medical centers and outpatient facilities. To organize and manage this complex national equipment portfolio, the program utilizes a hierarchical product structure consisting of CLINs and SLINs. CLINs represent the therapeutic devices themselves such as TENS units, IFC devices, Shortwave Diathermy systems, and neuromodulation devices. Each CLIN captures the core technical requirements, performance parameters, and safety features of a specific electro-therapeutic modality. SLINs represent the corresponding accessories required for full device operation such as electrodes, lead wires, chargers, or modality-specific components. SLINs inherit universal MTR expectations while adding accessory-specific salient characteristics such as dimensions, materials, packaging quantities, and compatibility requirements. Together, the universal MTRs and the CLIN/SLIN structure provide a standardized, regulatory-compliant, clinically driven, and logistically robust acquisition model. This structure ensures that all electro-therapeutic devices and accessories procured under the recompete of the ETMPM-TENS procurement program are technically acceptable, interoperable, traceable, and ready for immediate clinical use supporting uninterrupted, safe, and effective pain-management therapy for Veterans across the VA healthcare enterprise.

a. MTRs: The MTRs establish the baseline technical, safety, usability, regulatory, and packaging standards required of every device/unit offered under the recompete ETMPM- TENS procurement program.

These requirements apply to all Contract Line Item Numbers (CLINs), which represent the fully assembled, FDA cleared therapeutic devices themselves. Device accessories, identified under Sub Line Item Numbers (SLINs), have their own separate accessory specific MTRs. Together, the CLIN and SLIN structure supported by the following universal MTRs ensures that every ETMPM TENS device and accessory supplied to the Department of Veterans Affairs (VA) is FDA cleared, clinically appropriate, fully operational out of the box, safe, durable, standardized across the VA enterprise, warranty protected, and traceable through serial and bar code labeling. This structure provides the VA with consistent national supply chain reliability, clear product accountability, and robust technical compliance for all devices and accessories procured under the recompete ETMPM-TENS procurement program.

b. CLINs: CLINs represent the primary therapeutic devices being procured, such as TENS units, IFC devices, Shortwave Diathermy devices (e.g., thermal and non‑thermal), and portable neuromodulation devices. Each CLIN corresponds to a distinct medical device with its own required performance parameters and technical characteristics.

CLINs are individually priced, technically evaluated, and serve as the basis for warranty, regulatory compliance, and product performance requirements.

i. CLIN Naming Convention: The program employs clearly defined naming conventions to ensure traceability and administrative clarity as follows

a) CLINs use a four‑digit alphanumeric identifier (e.g., X001, X002).

b) The first character of the CLIN indicates the period of performance:

c) “0” = Base Year;

d) “1–4” = Option Years One (1) through Four (4); and

e) “X” = Pre‑award or solicitation‑phase CLIN identification applicable across all periods of performance until the time of award.

f) The last three digits uniquely identify the device type.

c. SLINs: SLINs represent the accessories, components, and consumables associated with each device, such as electrodes, lead wires, chargers, and other device‑specific accessories. SLINs may be informational only (e.g., tracking of product categories only) or priced (e.g., separately priced products for ordering of specific accessory items).

SLINs inherit the universal MTRs applicable to the associated CLIN but also contain additional accessory‑specific salient characteristics for example, electrode dimensions, material requirements, gel properties, quantities per package, or skin‑sensitivity variants.

i. SLIN Naming Convention:

a) SLINs extend the CLIN with two (2) additional alphanumeric characters

(e.g., X001AA, X001AB).

b) Alphabetic SLINs (AA–ZZ, excluding I and O) are used for priced deliverables, such as the accessories associated with the CLIN.

c) Numeric SLINs (01–99) are used for informational tracking purposes only, administrative purposes, or unpriced product categories.

d) SLINs are always subordinate to their parent CLIN and cannot exist independently.

d. CLINs and SLINs Mapping:

i. CLIN X001 - Portable TENS Device;

ii. SLIN X001AA - TENS Electrodes (2 in.);

iii. SLIN X001AB - TENS Electrodes (2 in. x 4 in.);

iv. SLIN X001AC - TENS Electrodes (2 in. & 2 in. x 4 in., Sensitive Skin);

v. SLIN X001AD - TENS Electrodes (Offeror Proposed Alternate Options);

vi. CLIN X002 - Portable Interferential Current (IFC) Device;

vii. SLIN X002AA - IFC Electrodes (2 in.);

viii. SLIN X002AB - IFC Electrodes (2 in. x 4 in.);

ix. SLIN X002AC - IFC Electrodes (2 in. & 2 in. x 4 in., Sensitive Skin);

x. SLIN X002AD - IFC Electrodes (Offeror Proposed Alternate Options);

xi. CLIN X003 - Shortwave Diathermy Device (Thermal);

xii. CLIN X004 - Shortwave Diathermy Device (Non-thermal);

xiii. CLIN X005 - Portable Neuromodulation Device - For Headache Disorders;

and

xiv. SLIN X005AA - Neuromodulation Electrodes (Offeror…